Answer: Under clinical supervision with verified sourcing and proper dosing, peptide therapy is generally well tolerated for appropriate candidates
Mainous MR, Tso P, Berg RD, Deitch EA (1991) Studies of the route, magnitude, and time course of bacterial translocation in a model of systemic inflammation
The study had no placebo group, no randomisation, no blinding, no imaging-confirmed repair endpoint and no clear analytical confirmation that the second peptide was the defined TB-500 fragment
Sikiric et al., 2020b), along with suggested significance of NO-synthase and the basal formation of NO in stomach mucosa, greater than that seen in other tissues (Whittle et al., 1992), BPC 157 exhibits a general, effective competing with both L-arginine analogs (i.e., L-NAME) and L-arginine (Sikiric et al., 2014)
peptide therapy (Body Protection Compound-157) is a synthetic peptide derived from a naturally occurring protein in human gastric juice
SinoPepLab supplies BPC-157 research peptides in: Bulk quantities and custom manufacturing are also available for qualified research organizations
